VEXAS syndrome with granulomatosis with polyangiitis manifestation: retained in remission using methotrexate and infliximab-Reference-Cited by-同舟云学术

VEXAS syndrome with granulomatosis with polyangiitis manifestation: retained in remission using methotrexate and infliximab

Published:2023-10-04 Issue: Volume: Page:
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:

Author:

Oka Hideki¹^ORCID,Sumitomo Shuji¹^ORCID,Nishikubo Masashi²,Yamashita Daisuke³,Maruoka Hayato⁴,Shiroishi Yumi⁴,Shimizu Hayato¹⁵,Kanamori Maki⁵,Nishioka Hiroaki⁵^ORCID,Ohmura Koichiro¹

Affiliation:

1. Department of Rheumatology, Kobe City Medical Center General Hospital , Kobe, Hyogo, Japan

2. Department of Hematology, Kobe City Medical Center General Hospital , Kobe, Hyogo, Japan

3. Department of Pathology, Kobe City Medical Center General Hospital , Kobe, Hyogo, Japan

4. Department of Clinical Laboratory, Kobe City Medical Center General Hospital , Kobe, Hyogo, Japan

5. Department of General Internal Medicine, Kobe City Medical Center General Hospital , Kobe, Hyogo, Japan

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

https://academic.oup.com/rheumatology/advance-article-pdf/doi/10.1093/rheumatology/kead536/52241765/kead536.pdf

Reference8 articles.

1. Somatic mutations in UBA1 and severe adult-onset auto-inflammatory disease;Beck;N Engl J Med,2020

2. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for eosinophilic granulomatosis with polyangiitis;Grayson;Ann Rheum Dis,2022

3. Relapsing polychondritis–report of ten cases;Damiani;Laryngoscope,1979

4. Efficacy and safety of biologics in relapsing polychondritis: a French national multicentre study;Moulis;Ann Rheum Dis,2018

5. Somatic mutations in UBA1 define a distinct subset of relapsing polychondritis patients with VEXAS;Ferrada;Arthritis Rheumatol,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prednisolone;Reactions Weekly;2024-07-27

2. VEXAS‐Defining UBA1 Somatic Variants in 245,368 Diverse Individuals in the NIH All Of Us Cohort;Arthritis & Rheumatology;2024-02-29

3. Clinical characteristics, disease trajectories and management of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome: a systematic review;Rheumatology International;2023-12-21

4. Analysis of 245,368 diverse individuals from the NIH All of Us Cohort identifies incomplete penetrance of the VEXAS-defining UBA1 p.M41L somatic mutation;2023-11-08